» Authors » Magdalena Krajewska-Wlodarczyk

Magdalena Krajewska-Wlodarczyk

Explore the profile of Magdalena Krajewska-Wlodarczyk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 270
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Knapik M, Owczarczyk-Saczonek A, Jaskiewicz L, Kuna J, Chmielewski G, Krajewska-Wlodarczyk M
J Clin Med . 2025 Jan; 14(1. PMID: 39797202
The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a rare condition caused by an immune response associated with over-reactivity of the immune system, triggered by adjuvants. The most common adjuvants...
2.
Batko B, Szelag M, Krajewska-Wlodarczyk M, Zuber Z, Orleanski M, Podwojcic K, et al.
Rheumatology (Oxford) . 2024 Dec; PMID: 39689029
Objectives: To investigate the association between risk of different co-morbidities and diagnosis of rheumatoid arthritis (RA) using a temporal approach. Methods: Retrospective, case-control study. Data were extracted from all healthcare...
3.
Fraczek A, Kuna J, Rybak dObyrn J, Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A
J Clin Med . 2024 Oct; 13(20). PMID: 39458184
Calcinosis cutis (CC) is a condition that may develop in the course of several autoimmune connective tissue diseases (ACTDs). Among these, the conditions most frequently associated with CC are systemic...
4.
Smolen J, Trefler J, Racewicz A, Jaworski J, Zielinska A, Krogulec M, et al.
RMD Open . 2024 Oct; 10(4). PMID: 39424404
Objectives: To demonstrate efficacy equivalence of CT-P47 and EU-approved reference tocilizumab (r-TCZ) in patients with rheumatoid arthritis (RA). Methods: This double-blind, phase III study randomised (1:1) patients to receive CT-P47...
5.
Stajszczyk M, Batko K, Zuber Z, Kwiatkowska B, Krajewska-Wlodarczyk M, Batko B
BioDrugs . 2024 Jun; 38(4):557-569. PMID: 38861154
Objectives: To evaluate the pricing of etanercept (ETN) reference and biosimilar drugs in a changing competitive to monopolized market. Methods: We conducted a comprehensive, retrospective analysis of ETN market competition,...
6.
Knapik M, Zelazo D, Osowiecka K, Krajewska-Wlodarczyk M
J Clin Med . 2024 May; 13(10). PMID: 38792403
: This study aimed to evaluate the efficacy of anti-interleukin-1 therapeutics for treating knee osteoarthritis (KOA). Our research included interleukin-1 (IL-1) inhibitors, IL-1 antibodies and IL-1 receptor antagonists (IL-1 Ras)....
7.
Krajewska-Wlodarczyk M, Szelag M, Batko B, Zuber Z, Orleanski M, Podwojcic K, et al.
Rheumatol Int . 2024 Apr; 44(6):1155-1163. PMID: 38678142
To assess the incidence and prevalence of rheumatoid arthritis (RA) in Poland for the period 2013-2021, total and dependent on gender, age, region and serological status. Information on reported National...
8.
Kitala-Tanska K, Socha K, Juskiewicz J, Krajewska-Wlodarczyk M, Majewski M
Nutrients . 2024 Apr; 16(8). PMID: 38674863
Copper (Cu), being an essential mineral, plays a crucial role in maintaining physiological homeostasis across multiple bodily systems, notably the cardiovascular system. However, an increased Cu level in the body...
9.
Kwiatkowska B, Krajewska-Wlodarczyk M, Batko B, Maslinska M, Stajszczyk M, Swierkot J, et al.
Reumatologia . 2024 Apr; 62(1):4-17. PMID: 38558893
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low-virulence variants of SARS-CoV-2 remain predominant, they pose an increased risk of...
10.
Kuna J, Chmielewski G, Jaskiewicz L, Krajewska-Wlodarczyk M
Medicina (Kaunas) . 2024 Mar; 60(3). PMID: 38541118
Macrophage activation syndrome is an uncommon yet dangerous and potentially fatal complication of many rheumatic diseases, inducing multiple organ failure, including, although rarely, acute heart failure. In the following paper,...